Synthesis and separation of tritiated inhibitors of aminopeptidase A and their prodrugs

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 47, Issue 13, 2004, Pages 997-1005

  Inguimbert, Nicolas ^a   Coric, Pascale ^a   Dhotel, Hélène ^a   Llorens Cortes, Catherine ^b   Fournié Zaluski, Marie Claude ^a   Roques, Bernard P ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Paris Sciences et Lettres   (France)

Author keywords

3H; Aminopeptidase A; Cardiovascular; Inhibitors; Thiol compounds

Indexed keywords

BIOCHEMISTRY; COVALENT BONDS;

3-AMINO-1; 3H; AMINO PEPTIDASE; AMINOPEPTIDASE A; CARDIOVASCULAR; INHIBITOR; PRODRUGS; SYNTHESISED; THIOL COMPOUNDS; TRITIUM ATOMS;

SULFUR COMPOUNDS;

2,2 DIMETHYLPROPYL ESTER; 3 AMINO 4 SULFANYLBUTANE 1 SULFONIC ACID 2,2 DIMETHYLPROPYL ESTER TRIFLUOROACETATE; 4,4' DITHIOBIS(3,3' AMINO) 1,1' BUTANESULFONIC ACID; 4,4' DITHIOBIS(3,3' AMINO) 1,1' BUTANESULFONIC ACID 2,2 DIMETHYLPROPYL ESTER TRIFLUOROACETATE H 3; AMINOPEPTIDASE INHIBITOR; ENZYME INHIBITOR; PRODRUG; RB 150; RB 151; TRITIUM; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL BOND; DRUG BIOAVAILABILITY; DRUG PURIFICATION; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; ISOTOPE LABELING; REDUCTION; SEPARATION TECHNIQUE; STRUCTURE ACTIVITY RELATION;

TRITIUM;

EID: 10344243569     PISSN: 03624803     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlcr.888     Document Type: Article

References (24)

1. Li L, Wu Q, Wang J, Bucy RP, Cooper MD. Tissue Antigens 1993; 42: 488-496.
2. Zini S, Masdehors P, Lenkei Z, Fournié-Zaluski MC, Roques BP, Corvol P, Llorens-Cortes C, Neurosciences 1997; 78: 1187-1193.
3. Migaud M, Durieux C, Viereck J, Soroca-Lucas E, Fournié-Zaluski MC, Roques BP. Peptides 1996; 17: 601-607.
4. Nagatsu I, Nagatsu T, Yamamoto T, Glenner GG, Mehl JW. Biochim Blophys Acta 1970; 198: 255-270.
5. Healy DP, Wilk S. Brain Research 1993; 606: 295-303.
6. Noble F, Wank SA, Crawley JN, Bradwejn J, Seroogy KB, Hamon M, Roques BP. Pharmacol Rev 1999; 51: 745-781.
7. Taghzouti K, Lena I, Dellu F, Roques BP, Dauge V, Simon H. Psychopharmacology 1999; 143: 141-149.
8. Singh L, Lewis AS, Field MJ, Hughes J, Woodruff GN. Proc Natl Acad Sci. 1991; 88: 1130-1133.
9. Chauvel EN, Coric P, Llorens-Cortes C, Wilk S, Roques BP, Fournié-Zaluski MC. J Med Chem 1994; 37: 1339-1346.
10. Reaux A, De Mota N, Zini S, Cadel S, Fournié-Zaluski MC, Roques BP, Corvol P, Llorens-Cortes C. Neuroendocrinology 1999; 69: 370-376.
11. Reaux A, Iturrioz X, Vazeux G, Fournié-Zaluski MC, David C, Roques BP, Corvol P, Llorens-Cortes C. Biochem Soc Trans 2000; 28: 435-440.
12. Marchio S, Lahdenranta J, Schlingemann RO, Valdembri D, Wesseling P, Arap MA, Hajitou A, Ozawa MG, Trepel M, Giordano RJ, Nanus DM, Dijkman HBPM, Oosterwijk E, Sidman RL, Cooper MD, Bussolino F, Pasqualini R, Arap W. Cancer Cell 2004; 5: 151-162.
13. Roques BP, Corvol P, Fournié-Zaluski MC, Llorens-Cortes C. Patent WO 09936066.
14. David C, Bischoff L, Meudal H, Mothe A, De Mota N, DaNascimento S, Llorens-Cortes C, Fournié-Zaluski MC, Roques BP. J Med Chem 1999; 42: 5197-5211.
15. David-Basei C, Bischoff L, Fournié-Zaluski MC, Roques BP. J Label Compd Radiopharm 2001; 44: 89-98.
16. Zini S, Fournié-Zaluski MC, Chauvel E, Roques BP, Corvol P, Llorens-Cortes C. Proc Natl Acad Sci 1996; 93: 11968-11973.
17. Fournié-Zaluski MC, Coric P, Turcaud S, Lucas E, Noble F, Moldonado R, Roques BP. J Med Chem 1992; 35: 2473-2481.
18. Roques BP, Corvol P, Fournié-Zaluski MC, Llorens-Cortes C. Patent WO 2004007441A2.
19. Fournié-Zaluski MC, Fassot C, Valentin B, Djordjijevic D, Reaux-Le Goazigo A, Corvol P, Roques BP, Llorens-Cortes C. Proc Natl Acad Sci USA 2004; 101: 7775-7780.
20. Shifen M, Xiaojing D, Yongjian L. Chromatog B 2002; 782: 251-267.
21. Mashimoto N, Aoyama T, Shiori T. Chem Pharm Bull 1981; 29: 1475-1478.
22. David C, Bischoff L, Roques BP, Fournié-Zaluski M-C. Tetrahedron 2000; 56: 209-215.
23. Carretero JC, Demillequand M, Ghosez L. Tetrahedron Lett 1987; 43: 5125-5134.
24. Kumar P, Bose NK, Gupta KC. Tetrahedron Lett 1991; 32: 967-970.